{"name": "oxitropium", "category": "drug", "content": "Oxitropium bromide (trade names Oxivent, Tersigan) is an anticholinergic used as a bronchodilator for the treatment of asthma and chronic obstructive pulmonary disease. It was patented in 1966 and approved for medical use in 1983.   == Synthesis ==  The natural product, norscopolamine (1), is converted by two alkylation reactions into oxitropium bromide. The first, with bromoethane, gives the N-ethyl intermediate (2), which is treated with bromomethane.    == References =="}